38 CFR Part 4 — 38 CFR § 4.117

Agranulocytosis, acquired — VA Diagnostic Code 7702

Hematologic / lymphatic

Diagnostic code

7702

Start free worksheet Get the Founding Pass — $9.99/month

38 CFR § 4.117 lists Diagnostic Code 7702 as “Agranulocytosis, acquired:”. The title ends with a colon. The lines are 100, 60, 30, and 10. None of those cells ends with a period. The note addresses a bone marrow transplant. It does not end with a period. Appendix B to Part 4 indexes “Agranulocytosis, acquired.” The index uses a period, not the colon.

Reviewed 2026-10-05. Text checked against the eCFR versioner full-text XML for 2026-10-01 on 2026-10-05. Title 38 was up to date as of 2026-10-01 and last amended on 2026-08-27. The § 4.117 source note prints 60 FR 49227, Sept. 22, 1995, as amended at 77 FR 6467, Feb. 8, 2012; 79 FR 2100, Jan. 13, 2014; 83 FR 54254, Oct. 29, 2018; 83 FR 54881, Nov. 1, 2018; 87 FR 61248, Oct. 11, 2022. The § 4.31 source note prints 58 FR 52018, Oct. 6, 1993.

The rating criteria at each level

7702 Agranulocytosis, acquired

Rating %: 100

Criteria (verbatim). Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period

Rating %: 60

Criteria (verbatim). Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period

Rating %: 30

Criteria (verbatim). Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period

Rating %: 10

Criteria (verbatim). Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl

Rating %	Criteria (verbatim)
100	Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period
60	Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period
30	Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period
10	Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl

Note: A 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue with a mandatory VA examination six months following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter

The note does not end with a period. It applies to a bone marrow transplant. It does not reprint the infection clause of the 100 percent line.

The 60 percent cell opens a parenthesis after “myeloid growth factors.” That parenthesis is not closed before the semicolon. The cell prints “less than 1000/µl;” with no closing parenthesis there. G-CSF, GM-CSF, and continuous immunosuppressive therapy such as cyclosporine follow that opening parenthesis. The 30 and 10 percent cells do not open it.

38 CFR § 4.31 says that in every instance where the schedule does not provide a zero percent evaluation for a diagnostic code, a zero percent evaluation shall be assigned when the requirements for a compensable evaluation are not met. DC 7702 does not print a 0 percent line. The lowest printed line is 10. 38 CFR § 4.7 assigns the higher rating when the disability picture more nearly approximates the criteria required for that rating. Otherwise, the lower rating will be assigned. 38 CFR § 4.6 requires each element affecting the evidence to be studied so that decisions will be equitable and just.

The 100 percent line is bone marrow transplant, or infections recurring, on average, at least once every six weeks per 12-month period. The note is the continuation rule for the transplant branch. It assigns 100 percent as of the date of hospital admission and continues it with a mandatory VA examination six months following hospital discharge. Any change based on that examination, or a later one, is subject to 38 CFR § 3.105(e). The note does not state a payment amount.

DC 7703 is the next row, “Leukemia (except for chronic myelogenous leukemia):”. Its 100 percent line is active disease or a treatment phase. Its Note (1) is a different six-month sentence. The agranulocytosis note is printed above DC 7703. It is not a DC 7703 note.

Source: 38 CFR § 4.117, Diagnostic Code 7702, eCFR full-text XML for 2026-10-01.

What the words mean in your records

Six weeks, three months, and once per year

The 100 percent infection clause is at least once every six weeks per 12-month period. The 60 percent infection clause is at least once every three months. The 30 percent infection clause is at least once per 12-month period but less than once every three months. The words “on average” are on each of those three clauses.

The neutrophil counts are not the same

The 60 percent therapy clause keeps ANC greater than 500/microliter (µl) but less than 1000/µl. The 30 percent line keeps ANC greater than 1000/µl. The 10 percent line keeps ANC greater than or equal to 1500/µl. The 10 percent line says “a myeloid growth factor,” singular.

The parenthesis is not closed

On the 60 percent line, a parenthesis opens after “growth factors.” The cell does not print a closing parenthesis before “1000/µl;”. G-CSF, GM-CSF, and “or continuous immunosuppressive therapy such as cyclosporine” follow that opening parenthesis. The infection clause is after the semicolon.

Evidence that speaks to each level

100

What the rater needs to see. A bone marrow transplant, or infections recurring, on average, at least once every six weeks per 12-month period. The transplant note also needs the hospital admission date and the examination six months after discharge.

Where that usually lives. The transplant admission and discharge records, or the dated infection record for those 12 months.

60, 30, or 10

What the rater needs to see. The myeloid growth factor or medication the line names, and the ANC threshold that line prints, or the infection frequency that line prints.

Where that usually lives. The treatment record and the absolute neutrophil count. The 60 percent line is the one that names G-CSF, GM-CSF, and cyclosporine.

Level	What the rater needs to see	Where that usually lives
100	A bone marrow transplant, or infections recurring, on average, at least once every six weeks per 12-month period. The transplant note also needs the hospital admission date and the examination six months after discharge.	The transplant admission and discharge records, or the dated infection record for those 12 months.
60, 30, or 10	The myeloid growth factor or medication the line names, and the ANC threshold that line prints, or the infection frequency that line prints.	The treatment record and the absolute neutrophil count. The 60 percent line is the one that names G-CSF, GM-CSF, and cyclosporine.

VA’s public DBQ list, checked October 5, 2026, names “Hematologic and Lymphatic Conditions, Including Leukemia” under Hematologic & Lymphatic. The file is Hematologic and Lymphatic Conditions, Including Leukemia.

The exam form

DC 7702 prints 100, 60, 30, and 10, and a transplant note that does not end with a period. This page does not say the form replaces those lines.

Related codes and how they interact

Leukemia is the next code, with a different note.

DC 7703 excepts chronic myelogenous leukemia from its title. The agranulocytosis note sits on the line above that title. Sharing the hemic schedule does not move the transplant note onto leukemia.

Secondary conditions and presumptions

The 2026-10-01 text of 38 CFR § 3.309 does not contain “agranulocytosis.” Section 3.309(a) lists “Leukemia.” without a diagnostic code. That family name is not assigned to DC 7702. DC 7703 is the leukemia row in § 4.117.

A separate question, when a presumption does not decide it, is a medical question on the facts under 38 CFR § 3.310. Paragraph (a) covers disability proximately due to or the result of a service-connected disease or injury. Paragraph (b) covers increase in severity and requires a medical baseline.

Short answers

What is the VA rating for acquired agranulocytosis?

Under 38 CFR § 4.117, Diagnostic Code 7702 is 100, 60, 30, or 10 percent on the lines printed there. The transplant note names § 3.105(e) and does not end with a period. Education only. VA decides on the evidence.

Is leukemia under this code?

No. DC 7703 is leukemia, except chronic myelogenous leukemia. Section 3.309 lists “Leukemia.” and does not assign DC 7702.

FAQ

How does VA rate acquired agranulocytosis under DC 7702?

The lines are 100, 60, 30, and 10 percent. They use either a treatment clause or an infection-frequency clause. The 100 percent infection clause is at least once every six weeks. The note continues a bone-marrow-transplant evaluation from hospital admission through an examination six months after discharge. Education only.

Does the note cover the infection clause?

The note says a 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission. It does not reprint the six-week infection clause, and it does not end with a period.

Does the 60 percent cell close its parenthesis?

It opens a parenthesis after “myeloid growth factors” and does not print a closing parenthesis before “1000/µl;”. G-CSF, GM-CSF, and continuous immunosuppressive therapy such as cyclosporine follow that opening parenthesis. The three-month infection clause is after the semicolon.

Next steps

Read the decision for DC 7702, the ANC figures, the infection dates, and any transplant admission and six-month examination.
The free worksheet is a place to write the code, the findings, and the records you already have. It does not file a claim or protect a filing date. An accredited representative is at find a VSO.
Other hematologic codes are on the hematologic diagnostic-code index.

Education only. Not legal or medical advice. My Claim Packet is not a VA-accredited representative and does not file claims. VA decides every claim on its own evidence.

Other codes in this body system

Nearby catalog entries in Hematologic / lymphatic, ordered by diagnostic code number. All Hematologic / lymphatic codes

Also: DC code lookup (tools) lists the same index in a compact layout.

Source: 38 CFR Part 4, Diagnostic Code 7702 • va.gov

⚠️ Important Disclaimer

This page provides general educational information based on public VA regulations and VA.gov resources. It is not legal or medical advice, and My Claim Packet is not a VA-accredited representative. Any worksheets or draft documents produced by the tools must be reviewed for accuracy and are not filed with VA for you. Ratings and service connection are decided case-by-case from the individual record. Consult a VA-accredited VSO, claims agent, attorney, or qualified clinician for help with your situation, and verify current rules using the linked official source.